Bier UW

No ORCID on file · 1 paper in corpus

article 1997

Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur®), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome

European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/s0301-2115(97)02733-4

ObjectiveIn our previous study, 119 patients with histologically confirmed endometriosis underwent a 'three-step' therapy between 1987 and 1989, where surgical removal of endometriosis was followed by a 6 month treatment with 3 x 300 microg…